title: Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study.
authors: Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy.
authors: Francesca
authors: F
authors: Lombardi
authors: Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy.
authors: Simone
authors: S
authors: Belmonti
authors: Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy.|Division of Infectious Diseases, Department of Internal Medicine, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
authors: Massimiliano
authors: M
authors: Fabbiani
authors: Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy al.bor86@gmail.com.
authors: Alberto
authors: A
authors: Borghetti
authors: Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy.
authors: Roberto
authors: R
authors: Cauda
authors: Department of Medical Biotechnologies, University of Siena, Viale Bracci 16, 53100 Siena, Italy.|University Division of Infectious Diseases, Hospital Department of Specialized and Internal Medicine, Viale Bracci 16, 53100 Siena, Italy.
authors: Andrea
authors: A
authors: De Luca
authors: Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy.
authors: Simona
authors: S
authors: Di Giambenedetto
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D000069446:Atazanavir Sulfate / Q000008:administration & dosage / Q000627:therapeutic use*; D004279:DNA, Viral / Q000097:blood*; D006678:HIV / Q000187:drug effects*; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage / Q000627:therapeutic use*; D007963:Leukocytes, Mononuclear / Q000821:virology; D010865:Pilot Projects; D016133:Polymerase Chain Reaction; D019438:Ritonavir / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D004279:DNA, Viral; D017320:HIV Protease Inhibitors; D019259:Lamivudine; D000069446:Atazanavir Sulfate; D019438:Ritonavir